| Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients O Itzhaki, E Jacoby, A Nissani, M Levi, A Nagler, A Kubi, K Brezinger, ... Journal for immunotherapy of cancer 8 (1), 2020 | 52 | 2020 |
| Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy A Nissani, S Lev-Ari, T Meirson, E Jacoby, N Asher, G Ben-Betzalel, ... Journal for ImmunoTherapy of Cancer 9 (5), 2021 | 38 | 2021 |
| Hepatitis C virus enhances the invasiveness of hepatocellular carcinoma via EGFR-mediated invadopodia formation and activation L Ninio, A Nissani, T Meirson, T Domovitz, A Genna, S Twafra, ... Cells 8 (11), 1395, 2019 | 29 | 2019 |
| Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response MJ Besser, O Itzhaki, G Ben‐Betzalel, DB Zippel, D Zikich, A Kubi, ... Molecular carcinogenesis 59 (7), 736-744, 2020 | 27 | 2020 |
| 441 Identification and utilization of TCRs targeting recurrent mutations in uveal melanoma OA Cohen, D Zikich, O Dotan, A Nissani, L Zeltzer, S Killim, O Harush, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
